绘制人肺中ABC转运体景观:P-gp、MRP1和BCRP在人肺上皮细胞中的表达和功能活性的综合表征

IF 4.7 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Sina Simon, Thanusa Shanmugalingam, Tobias Neu, Nicole Schneider-Daum, Carina Cantrill, Claus-Michael Lehr
{"title":"绘制人肺中ABC转运体景观:P-gp、MRP1和BCRP在人肺上皮细胞中的表达和功能活性的综合表征","authors":"Sina Simon, Thanusa Shanmugalingam, Tobias Neu, Nicole Schneider-Daum, Carina Cantrill, Claus-Michael Lehr","doi":"10.1016/j.ejps.2025.107333","DOIUrl":null,"url":null,"abstract":"<p><p>Active efflux transporters can play a substantial role in the drug disposition of their substrates in the human body. Efflux transporters like P-glycoprotein (P-gp), multidrug resistance associated protein 1 (MRP1) and breast cancer resistance protein (BCRP) were described to be expressed in the human lung. However, there is conflicting data reported regarding their expression and functional activity in the human lung epithelium in vitro. In this study, the expression and functional efflux of P-gp, MRP1 and BCRP was investigated in cell lines and primary cells derived from human upper (16HBE14o-, Calu-3, NHBE) and lower airways (NCI-H441, A549, hAELVi, Arlo and hAEpC). Additionally, the impact of culture condition, air liquid interface (ALI) vs liquid covered condition (LCC), on transporters' expression levels and efflux was evaluated. Gene and protein expression analysis revealed a ubiquitous expression of MRP1, while BCRP was present in most cells, except Calu-3, Arlo and hAEpC and P-gp was absent in all cells apart from Calu-3. Culturing the cells at ALI vs. LCC condition had only a significant impact on P-gp and MRP1 protein expression levels in Calu-3, which were both reduced at LCC. The functional activity of the expressed efflux transporters was demonstrated by the intracellular accumulation of fluorophore substrates in absence and presence of transporter specific inhibitors. However, bidirectional transport studies using drug substrates did not result in any observed efflux mediated by MRP1 and BCRP across any of the lung epithelial cells. Only P-gp, expressed in Calu-3 at ALI, showed functional activity in this experimental setting. In addition, it was observed that not all tested cells are suitable for studying pulmonary drug disposition processes in vitro due to their inability to form a tight cell barrier. Overall, the results of this study indicate differences in drug transporters' expression levels across human lung epithelial cells. Moreover, the efflux of model fluorophores for P-gp, MRP1 and BCRP was determined, whereas no such efflux was observed for MRP1 and BCRP when using drugs as substrates.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107333"},"PeriodicalIF":4.7000,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mapping the ABC Transporter Landscape in the Human Lung: A Comprehensive Characterisation of P-gp, MRP1 and BCRP Expression and Functional Activity in Human Lung Epithelial Cells.\",\"authors\":\"Sina Simon, Thanusa Shanmugalingam, Tobias Neu, Nicole Schneider-Daum, Carina Cantrill, Claus-Michael Lehr\",\"doi\":\"10.1016/j.ejps.2025.107333\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Active efflux transporters can play a substantial role in the drug disposition of their substrates in the human body. Efflux transporters like P-glycoprotein (P-gp), multidrug resistance associated protein 1 (MRP1) and breast cancer resistance protein (BCRP) were described to be expressed in the human lung. However, there is conflicting data reported regarding their expression and functional activity in the human lung epithelium in vitro. In this study, the expression and functional efflux of P-gp, MRP1 and BCRP was investigated in cell lines and primary cells derived from human upper (16HBE14o-, Calu-3, NHBE) and lower airways (NCI-H441, A549, hAELVi, Arlo and hAEpC). Additionally, the impact of culture condition, air liquid interface (ALI) vs liquid covered condition (LCC), on transporters' expression levels and efflux was evaluated. Gene and protein expression analysis revealed a ubiquitous expression of MRP1, while BCRP was present in most cells, except Calu-3, Arlo and hAEpC and P-gp was absent in all cells apart from Calu-3. Culturing the cells at ALI vs. LCC condition had only a significant impact on P-gp and MRP1 protein expression levels in Calu-3, which were both reduced at LCC. The functional activity of the expressed efflux transporters was demonstrated by the intracellular accumulation of fluorophore substrates in absence and presence of transporter specific inhibitors. However, bidirectional transport studies using drug substrates did not result in any observed efflux mediated by MRP1 and BCRP across any of the lung epithelial cells. Only P-gp, expressed in Calu-3 at ALI, showed functional activity in this experimental setting. In addition, it was observed that not all tested cells are suitable for studying pulmonary drug disposition processes in vitro due to their inability to form a tight cell barrier. Overall, the results of this study indicate differences in drug transporters' expression levels across human lung epithelial cells. Moreover, the efflux of model fluorophores for P-gp, MRP1 and BCRP was determined, whereas no such efflux was observed for MRP1 and BCRP when using drugs as substrates.</p>\",\"PeriodicalId\":12018,\"journal\":{\"name\":\"European Journal of Pharmaceutical Sciences\",\"volume\":\" \",\"pages\":\"107333\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-10-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Pharmaceutical Sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ejps.2025.107333\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejps.2025.107333","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

主动外排转运体在其底物在人体内的药物处置中发挥重要作用。外排转运蛋白如p -糖蛋白(P-gp)、多药耐药相关蛋白1 (MRP1)和乳腺癌耐药蛋白(BCRP)在人肺中表达。然而,关于它们在体外人肺上皮中的表达和功能活性,有相互矛盾的数据报道。本研究研究了P-gp、MRP1和BCRP在人上气道(16HBE14o-、Calu-3、NHBE)和下气道(NCI-H441、A549、hAELVi、Arlo和hAEpC)细胞系和原代细胞中的表达和功能外排。此外,还评估了培养条件、气液界面(ALI)和液体覆盖条件(LCC)对转运蛋白表达水平和外排的影响。基因和蛋白表达分析显示,MRP1普遍表达,BCRP在除Calu-3、Arlo和hAEpC外的大多数细胞中均存在,P-gp在除Calu-3外的所有细胞中均不存在。ALI和LCC条件下培养的细胞仅对Calu-3中P-gp和MRP1蛋白表达水平有显著影响,LCC条件下P-gp和MRP1蛋白表达水平均降低。在缺乏和存在转运蛋白特异性抑制剂的情况下,细胞内荧光团底物的积累证明了外排转运蛋白的功能活性。然而,使用药物底物的双向转运研究并未导致MRP1和BCRP介导的任何肺部上皮细胞外排。在这个实验环境中,只有Calu-3中表达的P-gp显示出功能活性。此外,观察到并非所有被测试的细胞都适合体外研究肺药物处置过程,因为它们无法形成紧密的细胞屏障。总之,本研究结果表明药物转运体在人肺上皮细胞中的表达水平存在差异。此外,我们还测定了模型荧光团对P-gp、MRP1和BCRP的外排,而以药物为底物时,MRP1和BCRP没有外排。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Mapping the ABC Transporter Landscape in the Human Lung: A Comprehensive Characterisation of P-gp, MRP1 and BCRP Expression and Functional Activity in Human Lung Epithelial Cells.

Active efflux transporters can play a substantial role in the drug disposition of their substrates in the human body. Efflux transporters like P-glycoprotein (P-gp), multidrug resistance associated protein 1 (MRP1) and breast cancer resistance protein (BCRP) were described to be expressed in the human lung. However, there is conflicting data reported regarding their expression and functional activity in the human lung epithelium in vitro. In this study, the expression and functional efflux of P-gp, MRP1 and BCRP was investigated in cell lines and primary cells derived from human upper (16HBE14o-, Calu-3, NHBE) and lower airways (NCI-H441, A549, hAELVi, Arlo and hAEpC). Additionally, the impact of culture condition, air liquid interface (ALI) vs liquid covered condition (LCC), on transporters' expression levels and efflux was evaluated. Gene and protein expression analysis revealed a ubiquitous expression of MRP1, while BCRP was present in most cells, except Calu-3, Arlo and hAEpC and P-gp was absent in all cells apart from Calu-3. Culturing the cells at ALI vs. LCC condition had only a significant impact on P-gp and MRP1 protein expression levels in Calu-3, which were both reduced at LCC. The functional activity of the expressed efflux transporters was demonstrated by the intracellular accumulation of fluorophore substrates in absence and presence of transporter specific inhibitors. However, bidirectional transport studies using drug substrates did not result in any observed efflux mediated by MRP1 and BCRP across any of the lung epithelial cells. Only P-gp, expressed in Calu-3 at ALI, showed functional activity in this experimental setting. In addition, it was observed that not all tested cells are suitable for studying pulmonary drug disposition processes in vitro due to their inability to form a tight cell barrier. Overall, the results of this study indicate differences in drug transporters' expression levels across human lung epithelial cells. Moreover, the efflux of model fluorophores for P-gp, MRP1 and BCRP was determined, whereas no such efflux was observed for MRP1 and BCRP when using drugs as substrates.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.60
自引率
2.20%
发文量
248
审稿时长
50 days
期刊介绍: The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development. More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making. Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信